These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
779 related items for PubMed ID: 21857898
1. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898 [Abstract] [Full Text] [Related]
2. [Critical roles of matrix metalloproteinases secreted by leukemic cells in the pathogenesis of central nervous system leukemia]. Feng SR, Chen ZX, Cen JN, Shen HJ, Wang YY, Yao L. Zhonghua Xue Ye Xue Za Zhi; 2016 Dec 14; 37(12):1070-1076. PubMed ID: 28088972 [Abstract] [Full Text] [Related]
3. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? Feng S, Huang Y, Chen Z. Med Hypotheses; 2011 May 14; 76(5):618-21. PubMed ID: 21398042 [Abstract] [Full Text] [Related]
4. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Diabetologia; 2007 Jan 14; 50(1):202-11. PubMed ID: 17143608 [Abstract] [Full Text] [Related]
5. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. J Cereb Blood Flow Metab; 2007 Apr 14; 27(4):697-709. PubMed ID: 16850029 [Abstract] [Full Text] [Related]
6. Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an in vitro blood-brain barrier model. Liu X, Su P, Meng S, Aschner M, Cao Y, Luo W, Zheng G, Liu M. Int J Biol Sci; 2017 Apr 14; 13(11):1351-1360. PubMed ID: 29209140 [Abstract] [Full Text] [Related]
7. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. Huang W, Eum SY, András IE, Hennig B, Toborek M. FASEB J; 2009 May 14; 23(5):1596-606. PubMed ID: 19141539 [Abstract] [Full Text] [Related]
8. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. Jiao H, Wang Z, Liu Y, Wang P, Xue Y. J Mol Neurosci; 2011 Jun 14; 44(2):130-9. PubMed ID: 21318404 [Abstract] [Full Text] [Related]
9. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling. Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I. J Neurosci; 2012 Jun 27; 32(26):8845-54. PubMed ID: 22745485 [Abstract] [Full Text] [Related]
10. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Chen F, Ohashi N, Li W, Eckman C, Nguyen JH. Hepatology; 2009 Dec 27; 50(6):1914-23. PubMed ID: 19821483 [Abstract] [Full Text] [Related]
11. West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, Verma S. J Gen Virol; 2012 Jun 27; 93(Pt 6):1193-1203. PubMed ID: 22398316 [Abstract] [Full Text] [Related]
12. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. András IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. J Neurosci Res; 2003 Oct 15; 74(2):255-65. PubMed ID: 14515355 [Abstract] [Full Text] [Related]
13. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Feng S, Zou L, Wang H, He R, Liu K, Zhu H. Molecules; 2018 Sep 17; 23(9):. PubMed ID: 30227623 [Abstract] [Full Text] [Related]
14. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. Liu J, Jin X, Liu KJ, Liu W. J Neurosci; 2012 Feb 29; 32(9):3044-57. PubMed ID: 22378877 [Abstract] [Full Text] [Related]
15. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, Lou J, Gao Y, Wang S, Wang Y. J Ethnopharmacol; 2012 Jun 01; 141(2):714-20. PubMed ID: 21920425 [Abstract] [Full Text] [Related]
16. Mild hypothermia alleviates brain oedema and blood-brain barrier disruption by attenuating tight junction and adherens junction breakdown in a swine model of cardiopulmonary resuscitation. Li J, Li C, Yuan W, Wu J, Li J, Li Z, Zhao Y. PLoS One; 2017 Jun 01; 12(3):e0174596. PubMed ID: 28355299 [Abstract] [Full Text] [Related]
18. Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats. Zhao YJ, Nai Y, Li SY, Zheng YH. Eur Rev Med Pharmacol Sci; 2018 Dec 01; 22(23):8509-8518. PubMed ID: 30556894 [Abstract] [Full Text] [Related]
19. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. J Physiol; 2008 Apr 01; 586(7):1937-49. PubMed ID: 18258663 [Abstract] [Full Text] [Related]
20. MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Yang Y, Rosenberg GA. Methods Mol Biol; 2011 Apr 01; 762():333-45. PubMed ID: 21717368 [Abstract] [Full Text] [Related] Page: [Next] [New Search]